Mouse Prothrombin ELISA Kit

$407.00

Catalog Number: EMP3022-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EMP3022-1 Categories: , , Tag: Brand:

Additional information

Format

Sandwich ELISA

Entrez Gene

14061

Components

Biotinylated Mouse Prothrombin Antibody, Chromogen Substrate (1x), MIX Diluent Concentrate (10x), Mouse Prothrombin Microplate, Mouse Prothrombin Standard, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

0.47 ng/ml

Range

0.781 – 50 ng/ml

Samples Type

Cell Lysates, Plasma, Serum, Tissue Extract, Urine

Associated Disease

Alzheimer's Disease, Blood Disorder, Chronic Gastrointestinal Disorder, Sepsis

Species

Mouse

UniProt

P19221

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications citing Assaypro: Mouse Prothrombin ELISA Kit... (5 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Coagulation and Fibrinolysis Profiles in Mouse Breast Cancer 4T1 Tumor-Bearing Mice: A Characterization of Neutrophil-Associated Prothrombotic States

Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model

  • https://www.ahajournals.org/doi/abs/10.1161/ATVBAHA.125.324007
  • N Suzuki, A Suzuki, S Tamura, S Tokumaru… - … and Vascular Biology, 2025 - ahajournals.org
  • BACKGROUND: Antithrombin resistance (ATR) is a congenital thrombotic predisposition caused by abnormal prothrombin (FII). Abnormal FII with ATR characteristics, when converted …

Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques

Intraovarian Thrombin and Activated Protein C Signaling System Regulates Steroidogenesis during the Periovulatory Period

Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques

Loading data...